| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |